- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 172.61M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $684.76M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $714.01M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $152.12M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $169.51M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $36.49M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $36.02M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $41.91M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $38.49M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $849.62M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $891.21M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $866.55M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $903.33M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 139.71M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $162K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$34.08M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $429.82M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $452.97M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.19 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.19 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $11.34M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $20.68M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$26.04M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$32.02M |